Literature DB >> 7539875

Prospects for pharmacotherapy of schizophrenia.

D Pickar1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7539875     DOI： 10.1016/s0140-6736(95)90469-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  11 in total

Review 1.  Continuing clozapine treatment despite neutropenia.

Authors:  David Esposito; Frédéric Rouillon; Frédéric Limosin
Journal:  Eur J Clin Pharmacol       Date:  2004-11-30       Impact factor: 2.953

2.  Single- and multiple-dose pharmacokinetics of ziprasidone under non-fasting conditions in healthy male volunteers.

Authors:  J J Miceli; K D Wilner; R A Hansen; A C Johnson; G Apseloff; N Gerber
Journal:  Br J Clin Pharmacol       Date:  2000       Impact factor: 4.335

Review 3.  Community care of patients with schizophrenia: the role of the primary health care team.

Authors:  M King; I Nazareth
Journal:  Br J Gen Pract       Date:  1996-04       Impact factor: 5.386

Review 4.  A risk-benefit assessment of risperidone for the treatment of behavioural and psychological symptoms in dementia.

Authors:  M Zaudig
Journal:  Drug Saf       Date:  2000-09       Impact factor: 5.606

Review 5.  The newer, 'atypical' antipsychotic drugs--their development and current therapeutic use.

Authors:  T Kendrick
Journal:  Br J Gen Pract       Date:  1999-09       Impact factor: 5.386

Review 6.  Bodyweight change as an adverse effect of drug treatment. Mechanisms and management.

Authors:  H Pijl; A E Meinders
Journal:  Drug Saf       Date:  1996-05       Impact factor: 5.606

Review 7.  How do the atypical antipsychotics work?

Authors:  J Ananth; K S Burgoyne; R Gadasalli; S Aquino
Journal:  J Psychiatry Neurosci       Date:  2001-11       Impact factor: 6.186

Review 8.  Clozapine, a fast-off-D2 antipsychotic.

Authors:  Philip Seeman
Journal:  ACS Chem Neurosci       Date:  2013-11-18       Impact factor: 4.418

9.  Genomewide pharmacogenomic study of metabolic side effects to antipsychotic drugs.

Authors:  D E Adkins; K Aberg; J L McClay; J Bukszár; Z Zhao; P Jia; T S Stroup; D Perkins; J P McEvoy; J A Lieberman; P F Sullivan; E J C G van den Oord
Journal:  Mol Psychiatry       Date:  2010-03-02       Impact factor: 15.992

10.  Pharmacotherapy of schizophrenic patients: preponderance of off-label drug use.

Authors:  David Pickar; Jessie Vinik; John J Bartko
Journal:  PLoS One       Date:  2008-09-10       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.